Author:
Zimmermann Hanne M. L.,Davidovich Udi,van Bilsen Ward P. H.,Coyer Liza,Matser Amy,Prins Maria,van Harreveld Frenk
Abstract
AbstractBiomedical HIV-prevention strategies (BmPS) among men who have sex with men (MSM), such as pre-exposure prophylaxis (PrEP) and viral load sorting (VLS), are essential but relatively new and their uptake gradual. Using an extension of the causal attitude network approach, we investigated which beliefs are related to uptake of PrEP and VLS at each time-point. We included 632 HIV-negative MSM from the Amsterdam Cohort Studies from four data-waves between 2017 and 2019. We estimated weighted, undirected networks for each time-point, where we included pairwise interactions of PrEP and VLS uptake and related beliefs. PrEP use increased from 10 to 31% (p < 0.001), while VLS was reported by 7–10% at each time-point. Uptake of both BmPS was directly related to the perceived positive impact of the strategy on one’s quality of sex life and perceived supportive social norms. Overall network structure differed between time points, specifically in regard to PrEP. At earlier time points, perceptions of efficacy and affordability played an important role for PrEP uptake, while more recently social and health-related concerns became increasingly important.The network structure differed across data-waves, suggesting specific time changes in uptake motives. These findings may be used in communication to increase prevention uptake.
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe 2018 – 2017 data, WHO Regional Office for Europe, Editor (WHO Regional Office for Europe, 2018).
2. van Sighem, A. I. et al. HIV Monitoring Report 2021 Human Immunodeficiency Virus (HIV) Infection in the Netherlands (Stichting HIV Monitoring, 2021).
3. Fonner, V. A. et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS 30(12), 1973–1983 (2016).
4. Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363(27), 2587–2599 (2010).
5. McCormack, S. et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 387(10013), 53–60 (2016).